Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tygacil Drug Use Investigation (Tigecycline Evaluation Study For Safety And Effectiveness In Patient Infected With Multi-Drug Resistance.)

NCT01789905 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01789905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01789905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tygacil Drug Use Investigation (Tigecycline Evaluation Study For Safety And Effectiveness In Patient Infected With Multi-Drug Resistance.)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
April 15, 2013
Completion date
June 16, 2017
Enrollment
116 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intra-abdominal infections, skin disease, infectious